Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Hydroxycarbamide Stories

2013-09-10 14:24:24

Treatment for sickle cell disease has largely focused on managing pain and acute complications, but current research, including several projects at Texas Children’s Hematology Center, is now aimed at developing more efficient and progressive forms of treatment that could potentially benefit patients around the world. "Traditionally, treatment for sickle cell disease has been palliative, and there have not been a lot of options to prevent long term complications," said Dr. Alex George,...

2013-09-02 00:20:31

The St. Jude Children's Research Hospital-led national BABY HUG trial linked hydroxyurea to a 21 percent reduction in annual medical costs for young children with sickle cell anemia; savings expected to grow MEMPHIS, Tenn., Sept. 2, 2013 /PRNewswire-USNewswire/ -- A drug proven effective for treatment of adults and children with sickle cell anemia reduced hospitalizations and cut annual estimated medical costs by 21 percent for affected infants and toddlers, according to an analysis...

2013-08-19 08:28:31

SUSTAIN study to investigate the potential of a chronic SelG1 therapy to reduce or prevent the occurrence of sickle cell-related pain crises OKLAHOMA CITY, Aug. 19, 2013 /PRNewswire/ -- Selexys Pharmaceuticals Corporation, a privately held biopharmaceutical company that is developing therapies to treat inflammatory and thrombotic diseases, today announced that enrollment has been initiated in SUSTAIN, a Phase II, multicenter, randomized, placebo-controlled, double-blind, 12-month...

2013-06-10 08:30:34

SAN DIEGO, June 10, 2013 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized, double-blind, placebo-controlled Phase 2b study of HQK-1001 in patients with sickle cell disease. The study, initiated in July 2012, enrolled a total of 77 patients in clinical sites in the US, Canada, Jamaica, Egypt and Lebanon. HemaQuest...